GLP 3 RT
Price range: $180.00 through $320.00
99% Pure | USA Made | Multi Dose
GLP 3 RT is a cutting-edge tri-agonist peptide that is transforming the field of metabolic research. Engineered to simultaneously activate three key metabolic receptors—GLP-1, GIP, and GCGR (glucagon)—this multifunctional compound offers a comprehensive and synergistic approach to modulating appetite signaling, enhancing insulin function, and accelerating fat metabolism pathways in research settings.
What Is Trinity-X?
Trinity-X™ is a 39-amino-acid synthetic peptide engineered as a tri-agonist for the GLP-1, GIP, and glucagon receptors. By combining three receptor activities into a single stable compound, Trinity-X provides a powerful research tool to investigate multi-pathway metabolic control, including satiety signaling, insulin secretion dynamics, and lipid breakdown mechanisms—without requiring separate agonists for each pathway.
Why Choose Trinity-X?
Researchers choose Trinity-X when they need a single-molecule solution for complex metabolic-health studies. Its tri-agonist design delivers synchronized receptor activation that enables streamlined protocols for:
What Sets Trinity-X Apart?
Unlike single-pathway peptides or even dual-agonists, Trinity-X uniquely merges GLP-1, GIP, and glucagon receptor activities into one stable compound. This integrated tri-agonist approach produces synergistic metabolic effects that cannot be achieved with other research peptides:
FAQS
Trinity-X is a research-grade peptide known for its tri-agonist activity— activating GLP-1, GIP, and glucagon receptors simultaneously. It is being studied in scientific settings for its unique mechanism of action across multiple metabolic pathways.
The name “Trinity-X” refers to its triple-receptor mechanism—three pathways activated by one molecule. The “X” represents the cutting-edge, nextgeneration nature of this research compound.
No. Trinity-X is a synthetic peptide, engineered in laboratory settings to mimic and enhance the function of naturally occurring hormonal pathways in research models.
Trinity-X is commonly studied in metabolic, obesity, glucose regulation, and energy balance models. Its triple-receptor profile makes it an ideal candidate for preclinical exploration of multi-receptor metabolic interactions.
Research protocols often begin with 0.25mg and may scale to 0.5mg or 1mg, depending on the experimental model and study goals. Dosage should be determined based on internal SOPs and protocol requirements.
Yes. Dosage charts for Trinity-X are typically created based on model weight, study length, and receptor activation goals. Charts often show titration schedules from 0.25mg up to 1mg over several weeks.
Trinity-X is available in 10mg, 12mg, 20mg, and 24mg vial sizes, allowing researchers to select the optimal quantity for their specific protocols.
Yes. Trinity-X is frequently used in research stacks with peptides such as Tesamorelin, MOTS-c, 5-Amino-1MQ, or Cagrilintide to explore synergistic effects in metabolic modeling.
How does Trinity-X compare to single-receptor peptides?
Lyophilized Trinity-X should be stored at or below -20°C for long-term stability. After reconstitution, storage in a refrigerated environment (2-8°C) is recommended, with use within 7-14 days per research protocol.
Related Products
Related products
-
MOTS-c Nasal Spray ? 10mg
$200.00 -
This product has multiple variants. The options may be chosen on the product pageSemax Amidate
$60.00 -
GLOW Stack
$180.00 -
This product has multiple variants. The options may be chosen on the product pageAOD-9604
$70.00